Earnings

Why Allscripts Healthcare Solutions, Inc. (MDRX) Is Being Added to Investors Watchlist?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)’s interesting series of developments are underway around the US stock market these days. Now trading with a market value of 2.54B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MDRX, the company currently has 89.11 million of cash on the books, which is offset by 32.45 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 3.78 billion in total assets, balanced by 2.21 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Allscripts Healthcare Solutions, Inc. (MDRX) saw 23.37 million in free cash flow last quarter, representing a quarterly net change in cash of -15.28 million. Perhaps most importantly where cash movements are concerned, the company saw about 33.88 million in net operating cash flow.



Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 426.09 million in total revenues. That represents a quarterly year/year change in revenues of 0.10 in sequential terms, the MDRX saw sales decline by 0.03.

But what about the bottom line? After all, that’s what really matters in the end. Allscripts Healthcare Solutions, Inc. (MDRX) is intriguing when broken down to its core data. The cost of selling goods last quarter was 246.75 million, yielding a gross basic income of 179.35 million. For shareholders, given the total diluted outstanding shares of 181.19 million, this means overall earnings per share of -0.85. Note, this compares with a consensus analyst forecast of 0.12 in earnings per share for its next fiscal quarterly report.




Is Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 0.57 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 17.64. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Allscripts Healthcare Solutions, Inc..

Previous ArticleNext Article

Related Post

Dissecting the Numbers for Banco Bradesco S.A. (BB... Banco Bradesco S.A. (NYSE:BBD) shares are up more than 15.94% this year and recently increased 2.86% or $0.33 to settle at $11.86. Boston Scientific C...
National Instruments Corporation (NATI) vs. PDF So... National Instruments Corporation (NASDAQ:NATI) shares are up more than 44.16% this year and recently decreased -0.47% or -$0.21 to settle at $44.43. P...
Choosing Between Merck & Co., Inc. (MRK) and ... Merck & Co., Inc. (NYSE:MRK) shares are down more than -4.48% this year and recently decreased -0.54% or -$0.29 to settle at $53.75. Nuance Commun...
Should You Buy Boston Scientific Corporation (BSX)... Boston Scientific Corporation (NYSE:BSX) shares are up more than 5.32% this year and recently decreased -0.27% or -$0.07 to settle at $26.11. Hologic,...
Taking Tally Of ICICI Bank Limited (IBN), Honeywel... The shares of ICICI Bank Limited have decreased by more than -17.11% this year alone. The shares recently went up by 0.44% or $0.03 and now trades at ...